1. Home
  2. KITT vs CMND Comparison

KITT vs CMND Comparison

Compare KITT & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

N/A

Current Price

$1.60

Market Cap

2.4M

Sector

Industrials

ML Signal

N/A

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

N/A

Current Price

$0.72

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KITT
CMND
Founded
2014
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
KITT
CMND
Price
$1.60
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 712.2K
345.1K
Earning Date
11-13-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.55
N/A
EPS
N/A
★ N/A
Revenue
★ $11,434,959.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 33.10
N/A
52 Week Low
$0.39
$0.07
52 Week High
$3.65
$4.66

Technical Indicators

Market Signals
Indicator
KITT
CMND
Relative Strength Index (RSI) 65.78 27.14
Support Level $0.64 $0.59
Resistance Level $2.08 $1.27
Average True Range (ATR) 0.17 0.06
MACD 0.15 0.02
Stochastic Oscillator 46.71 5.84

Price Performance

Historical Comparison
KITT
CMND

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: